Clinical Complications

Peptic Ulcer: Complications & Clinical Risks

Peptic ulcers are open sores that develop on the inner lining of the stomach or the upper part of the small intestine. H. pylori infection and long-term NSAID use are the most common causes. They cause burning stomach pain, especially when the stomach is empty.

Overview of Major Complications

Gastrointestinal and hepatic conditions generate complications through mucosal barrier dysfunction, impaired nutrient absorption, portal hypertension, altered motility, and systemic effects of hepatic failure. Liver cirrhosis exemplifies the multi-system complication burden: portal hypertension causes variceal bleeding, ascites, and hepatorenal syndrome; liver synthetic failure impairs coagulation; portosystemic encephalopathy affects consciousness. Inflammatory bowel disease carries complications from bowel wall inflammation, malabsorption, extraintestinal manifestations, and immunosuppressive therapy.

Early Complications

  • ⚠Gastrointestinal haemorrhage — peptic ulcer, oesophageal varices, or Mallory-Weiss tear
  • ⚠Perforation — of peptic ulcer, diverticulitis, or inflamed bowel in IBD; surgical emergency
  • ⚠Cholangitis — biliary infection from obstruction; fever, jaundice, right upper quadrant pain (Charcot's triad)
  • ⚠Acute pancreatitis — rapid severe abdominal pain; may progress to necrotising pancreatitis
  • ⚠Toxic megacolon — fulminant colitis with colonic dilation; surgical emergency
  • ⚠Intestinal obstruction — from adhesions, hernia, or stricture; strangulation risk

Long-Term Complications

  • →Liver cirrhosis — end-stage of chronic hepatitis, NASH, alcohol-related liver disease; portal hypertension
  • →Hepatocellular carcinoma — occurs in >80% of cases on background of cirrhosis
  • →Oesophageal varices and variceal haemorrhage — 30–50% risk of bleeding within 2 years of diagnosis
  • →Spontaneous bacterial peritonitis (SBP) — in cirrhotic ascites; high mortality
  • →Hepatorenal syndrome — kidney failure in decompensated cirrhosis; poor prognosis
  • →Iron deficiency anaemia — chronic GI blood loss, malabsorption in coeliac disease and IBD
  • →Colorectal cancer — 2–5× increased risk in long-standing extensive ulcerative colitis
  • →Short bowel syndrome — from multiple bowel resections in Crohn's disease; nutritional dependency

Emergency Complications

Immediate clinical action required

  • ✕Acute variceal haemorrhage — vasoactive drugs (terlipressin), endoscopic band ligation, TIPS if refractory
  • ✕Acute liver failure — encephalopathy, coagulopathy; liver transplant assessment urgently
  • ✕Mesenteric ischaemia — acute bowel infarction; surgical emergency with high mortality
  • ✕Bowel perforation — urgent surgery; peritonitis from perforation carries >30% mortality
  • ✕Sepsis from SBP or cholangitis — broad-spectrum antibiotics and source control immediately

What Increases Complication Risk

  • ↑Alcohol use — primary driver of cirrhosis, pancreatitis, and GI haemorrhage
  • ↑Non-adherence to IBD therapy — leads to mucosal inflammation and complication accumulation
  • ↑NSAID use — increases peptic ulcer risk and risk of GI haemorrhage
  • ↑Metabolic syndrome and obesity — promotes NASH, gallstone disease, and colon cancer
  • ↑Smoking — worsens Crohn's disease activity and healing; increases GI cancer risk
  • ↑Previous GI haemorrhage — strong predictor of recurrent bleeding

What Reduces Complication Risk

  • ↓Alcohol abstinence — most effective intervention in alcohol-related liver disease; reverses early fibrosis
  • ↓Non-selective beta-blockers — reduce variceal bleeding risk by 40–50% in cirrhosis
  • ↓Antibiotic prophylaxis for SBP in high-risk cirrhotic patients
  • ↓Adherence to biologic or immunosuppressive therapy in IBD — maintains mucosal healing
  • ↓6-monthly liver ultrasound and AFP in cirrhosis — enables early HCC detection
  • ↓PPI therapy in high-risk patients on NSAIDs or with peptic ulcer history

When Urgent Reassessment is Needed

The following signs may indicate a new or worsening complication requiring prompt clinical evaluation:

  • ◆Haematemesis or melaena — upper GI bleeding; emergency endoscopy within 24 hours
  • ◆Sudden severe abdominal pain with peritonism — perforation or mesenteric ischaemia
  • ◆Jaundice with fever and right upper quadrant pain — cholangitis; urgent ERCP
  • ◆Confusion or encephalopathy in known liver disease — hepatic encephalopathy
  • ◆Ascites with fever and abdominal tenderness — spontaneous bacterial peritonitis
  • ◆New rectal bleeding or change in bowel habit in IBD — reassessment; exclude cancer

Special Populations

Elderly: higher NSAID-related GI complications; reduced hepatic blood flow affects drug metabolism; sarcopenia worsens liver disease prognosis
Paediatric IBD: growth failure and delayed puberty require monitoring; methotrexate and biologics used earlier
Pregnancy: acute fatty liver of pregnancy is obstetric emergency; IBD flares common; many hepatic drugs require dose adjustment
Immunosuppressed patients: increased risk of opportunistic GI infections; CMV colitis must be excluded in severe IBD flares

Related Clinical Pages

Treatment & Management

Evidence-based treatment pathway, medications, and escalation criteria

Prognosis & Outlook

Long-term clinical outlook, improving and worsening outcome factors

Differential Diagnosis

Conditions that mimic Peptic Ulcer — distinguishing features & tests

Evidence & Guidelines

Clinical trials, guideline strength, and treatment evidence

Peptic Ulcer Overview

Symptoms, causes, and general condition overview

Similar Conditions With Different Risk Profiles

These conditions share overlapping symptoms with Peptic Ulcer but have distinct complication patterns — understanding the differences is clinically important.

Gastritis vs Peptic UlcerCompare →GERD (Acid Reflux) vs Peptic UlcerCompare →

Concerned about Peptic Ulcer?

Describe your symptoms and get a structured clinical assessment — possible causes, red flags, and recommended next steps.

Start Free AI Analysis →

Medical References

Content on this page is informed by evidence-based clinical sources including: